Trial intelligence / Profile preview

Bactorinol in Chronic Rhinosinusitis

NCT07800273Not yet recruiting

Sponsor
Liaquat University of Medical and Health Sciences
Start
Sep 2026
Primary completion
May 2027
Countries
1
01

Overview

Randomised trial of mastic oil in chronic rhinosinusitis (CRS) (2 arms), sponsored by Liaquat University of Medical and Health Sciences. Primary endpoint: Sino-Nasal Outcome Test-22 at 12 weeks. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

mastic oil
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on NCT07800273.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07800273.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call